We examined the effect of adenovirus-mediated transient expression of Smad7, an inhibitory Smad in TGFb/ activin signaling, on injury-induced epithelial-mesenchymal transition (EMT) of lens epithelium in mice. A volume of 3 ll of adenoviral solution was injected into the right lens of adult male C57BL/6 mice (n ¼ 56) at the time of capsular injury made using a hypodermic needle under general anesthesia. A mixture of recombinant adenovirus carrying CAG promoter-driven Cre (Cre adv) and mouse Smad7 complementary DNA (Smad7 adv) was administered to induce Smad7 expression, while control lenses were treated with Cre adv alone. After healing intervals of 2, 3, 5, and 10 days, animals were killed 2 h after labeling with bromodeoxyuridine (BrdU) and eyes were processed for histology. During healing, marked expression of Smad7 was observed in lens epithelial cells in the Smad7 adv group with loss of nuclear translocation of Smads2/3, while little Smad7 and abundant nuclear Smads2/3 were seen in cells in the Cre adv group. Lens epithelial cells in the Cre adv control group exhibited a fibroblastic appearance at days 5 and 10 and the capsular break was sealed with fibrous tissue, while Smad7 adv-treated cells around the capsular break retained their epithelial morphology and the break was not sealed. Expression of snail mRNA, and a-smooth muscle actin, lumican, and collagen VI proteins, markers of EMT, was observed in control-treated eyes, but not in cells of the Smad7 adv group at day 5 with minimal expression at day 10. Additionally, cell proliferation increased in epithelium infected with Smad7 adv consistent with suppression of injury-induced upregulation of TGFb1 in epithelium. We conclude that gene transfer of Smad7 in mice prevents injury-induced EMT of lens epithelial cells and sealing of the capsular break with fibrous tissue.
Following injury, lens epithelial cells undergo epithelial-mesenchymal transition (EMT), [1] [2] [3] [4] which contributes to the formation of fibrotic tissue in the injured lens. [5] [6] [7] [8] A similar phenomenon is observed in the human lens capsule following cataract extraction and implantation of an artificial intraocular lens. Such an EMT-related fibrotic reaction is clinically unfavorable since it may cause opacification and contraction of the remaining anterior lens capsule, as well as opacification in the posterior capsule, all of which potentially impair vision. Eye aqueous humor contains abundant transforming growth factor b2 (TGFb2) 9, 10 and evidence suggests that TGFb is involved in injury-related EMT in lens epithelial cells. [11] [12] [13] [14] We have shown that endogenous TGFb2 induces a transient nuclear translocation of the TGFb signaling intermediates, Smads3/4 in lens epithelial cells postinjury in mice, which was inhibited by local administration of a neutralizing antibody against TGFb2, indicating that this growth factor isoform is responsible for the activation of Smads3/4 signaling in lens epithelium. 7 Human lens epithelial cells are also regulated by TGFb/ Smad signaling in vivo during wound healing. 15 We recently reported that TGFb/Smad3 signaling is critical in the induction of EMT in lens or renal epithelium in vivo by showing that EMT is blocked in Smad3-null mice, 16, 17 although in vitro studies suggest that a variety of signaling pathways may be required for EMT. [18] [19] [20] [21] [22] [23] Smad7 is an inhibitory Smad that interferes with Smad signaling by preventing the phosphorylation of Smads2/3, which normally occurs following binding of TGFb/activin to their cell surface receptors. [24] [25] [26] [27] Recently, transient introduction of the Smad7 gene using an adenovirus vector has been shown to be effective in treating tissue inflammatory/fibrotic disorders in lung, 28 kidney, 29 and liver. 30 Therefore, we hypothesized that transfer of Smad7 complementary DNA (cDNA) using a viral vector might also block injury-induced EMT in lens epithelial cells. In the present study, we created an adenoviral gene-transfer system to introduce Smad7 cDNA into an injured mouse lens and show that transient adenoviral gene transfer effectively blocks injury-induced EMT in lens epithelium while enhancing cell proliferation. These results suggest a potential therapeutic efficacy of Smad7 gene transfer in the treatment of postoperative capsular fibrosis.
Materials and methods
All the experimental procedures were approved by both the DNA Recombinant Experiment Committee and Animal Care and Use Committee of Wakayama Medical University, Wakayama, Japan, and conducted in accordance with the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research.
Adenovirus Vector Construction and Virus Purification
We used the Adenovirus Cre/LoxP-Regulated Expression Vector Set (#6151, Takara, Tokyo, Japan) to generate recombinant adenovirus. Cosmid pAxCALNLmSmad7 was constructed by the insertion of mouse Smad7 cDNA (a kind gift by Dr K Miyazono, The University of Tokyo School of Medicine, Tokyo, Japan) into the Swa I cloning site of pAxCALNLw. 31 Using the COS-TPC method, 32 recombinant adenovirus of AxCALNLmSmad7 was generated by transfecting 293 cells with pAxCALNLSmad7. AxCANCre was generated by transfecting 293 cells with Ax-CALNLCreDNA-TPC as described in the manufacturer's protocol. The titer of recombinant adenoviruses was measured by the 50% tissue culture infectious dose method. 33 Each adenovector was used at the concentration of 2 Â 10 7 PFU/ml. When these two viral vectors coinfect cells, Cre recombinase expressed under the CAG promoter (cytomegalovirus enhancer, chicken bactin promoter plus a part of 3 0 untranslated region of rabbit b-globin) activates the stuffer PolyA through the Cre/LoxP system.
Experimental Protocol
Evaluation of the efficacy of adenoviral gene transfer was performed by coinfection of viruses carrying Cre recombinase under the CAG promoter and LNLgreen fluorescent protein (GFP) or by infection of virus carrying GFP alone in an injured lens. The anterior lens capsule of the right eye of an adult C57BL/6 mouse was punctured as previously reported under general anesthesia by intraperitoneal (i.p.) pentobarbital. 7, 17 A volume of Three 3 ml of viral vector solution of either group was injected into the injured lens at the time of capsular injury. At days 1, 2, and 5 (n ¼ 2/group on each day) following injury, the right eye was enucleated and embedded in OCT compound. Cryosections (7 mm) were examined without fixation under fluorescence microscopy.
Upon confirmation of the expression of GFP in injured lens epithelial cells, we introduced Smad7 cDNA. One vector expresses Cre under the CAG promoter (CAG-Cre) while the other contains Smad7 that is activated by Cre recombinase (LNL-Smad7). The right eyes of 4-week-old male C57BL/6 mice (n ¼ 56) were used. To induce transcription of Smad7, both LNL-Smad7 and CAG-Cre vectors (3 ml total) were coinfected directly into the affected lens at the time of formation of a break in the anterior capsule as described above. Control lenses were treated with CAG-Cre alone (3 ml). At days 2 (n ¼ 3/group), 3 (n ¼ 3 /group), 5 (n ¼ 11/group), and 10 (n ¼ 11/group), post-treatment, the eyes were enucleated, fixed, and embedded in paraffin as previously reported. 7, 17 In Situ Hybridization for Snail Snail is a member of a family of zinc-fingercontaining transcriptional repressors increasingly associated with suppression of the epithelial phenotype associated with EMT. [34] [35] [36] Digoxigenin-labeled riboprobes for mouse snail and were prepared using a digoxigenin-labeling kit (Roche Diagnostics Corp-Boehringer Mannheim, Indianapolis, IN, USA). and in situ hybridization of paraffin sections (5 mm) was carried out as previously reported. 16, 17 Immunohistochemistry Deparaffinized sections (5 mm) were reacted with primary antibodies appropriately diluted with phos- BrdU immunostaining was performed as previously described. 38 In brief, deparaffinized sections were treated with 2 N HCl for 1 h at 371C, treated with anti-BrdU antibody (1:11 dilution in PBS, Roche Diagnostics, Mannheim, Germany) and then with peroxidase-conjugated secondary antibody after washing in PBS. Following the color reaction with diaminobenzidine and methyl green counterstaining, the number of labeled cells in healing epithelia was determined. Six specimens were counted in each group at days 5 and 10. Histology was observed by staining tissues with hematoxylin and eosin (HE).
Results

Efficacy of Adenovirus-Mediated Expression of GFP in Injured Lens Epithelial Cells
We confirmed that the CAG-Cre/LoxP system can efficiently introduce a gene of interest by observing the expression of GFP. When the injured lens epithelium was coinfected with adenoviral vectors encoding Cre under control of the CAG promoter and GFP under control of the LNL promoter, green fluorescence was observed at day 1 and later in lens epithelium, as well as in corneal endothelium and iris tissue (Figure 1a , b). No fluorescence was detected in eyes infected with CAG-Cre adv only.
Smad7 Expression and Inhibition of Smad3 Signaling
Our previous study showed that nuclear translocation of Smad proteins in lens epithelial cells following injury generally occurs before the cells form multilayers, but is also occasionally observed in the multilayers. At day 2 after infection, phosphorylated Smad2 (not shown) and Smad3 were detected in the nuclei of lens epithelial cells in the anterior lens adjacent to the capsular break ( Figure  1c , d) in control eyes, whereas in Smad7-infected eyes phospho-Smad2 (not shown) was not detected and Smad3 was seen only faintly in the cytoplasm of the anterior lens (Figure 1e, f) . A similar phenomenon was also observed even in the equatorial region apart from the injury site at the same time point.
Smad3 was detected in the nuclei of lens epithelial cells in the equatorial lens region (Figure 1g , h) in a control specimen, but not in the equatorial epithelia of the Smad7-infected group (Figure 1i, j) . At and after day 5, the majority of nuclei were negative for both Smads 2/3 in the control, and in Smad7 advtreated specimens (not shown). Smad7 protein, presumably the translated product derived from exogenously introduced Smad7 cDNA, was strongly detected in the healing lens epithelium from day 2 onward, while faint immunoreactivity for endogenous Smad7 was seen in the healing lens epithelium in the control group for up to 10 days (Figure 1k, l) . Rather, the Smad7-infected group showed round or ovoid epithelial-like cells surrounding the break. This finding strongly suggests that introduction of exogenous Smad7 cDNA inhibited EMT following injury.
Histology of Injured Lens Epithelial Cells and Expression of EMT Markers
To test this hypothesis, we first carried out in situ hybridization for snail mRNA in paraffin sections. Snail is a member of a family of zinc-fingercontaining transcriptional repressors increasingly associated with suppression of the epithelial phenotype associated with EMT. The results showed that, as previously reported, uninjured lens epithelium does not express snail mRNA (data not shown). Snail mRNA is upregulated in the injured lens epithelium of the control Cre adv-treated group (Figure 3a) , whereas eyes treated with Smad7 adv showed no expression of snail in injured epithelium at day 5 (Figure 3b ). At day 10, its expression in lens cells seemed to increase further (Figure 3c ) in the control Cre adv-treated group, while only faint expression of snail was detected in the cells of Smad7 adv-treated specimens (Figure 3d ). No specific signal was detected in specimens labeled with the sense probe (Figure 3e ).
To examine if snail expression is followed by EMT, we immunostained tissues with antibodies against specific markers for EMT, for example, aSMA, lumican, and collagen type VI. The results showed that there was no expression of aSMA in lens epithelial cells at 2 days postinjury in eyes of either the Smad7 adv-treated group or the control group. However, at day 5, marked immunofluorescence for aSMA was seen in multilayered cells in the control CAG/Cre adv-treated lens (Figure 4a ), but almost never in cells of Smad7 adv-treated lenses (Figure 4b ). At day 10, a strong immunofluorescence for aSMA was seen in control CAG/Cre group cells Smad7 blocks EMT in lens epithelium S Saika et al Figure 1 Detection of GFP, Smad3, or Smad7 by fluorescence in injured lens epithelium at day 1, 2, or 10. Expression of GFP was examined in an injured mouse lens coinfected with viruses carrying Cre under the CAG promoter and LNL-GFP or infected only with virus containing CAG/Cre. GFP expression is observed in coinfected lens epithelium (b, red arrows), but not in epithelium without GFPcarrying virus (a, white arrows). At day 2, Smad3 is detected in the nuclei of lens epithelial cells located adjacent to the capsular break (d) and lens equator (h) in a control, CAG/Cre-adenovirus-infected specimen, while faint cytoplasmic expression of Smad3 is observed in the injured lens epithelium adjacent to the break (f) and in the equator (j) in eyes coinfected with CAG/Cre-carrying and LNL/Smad7-carrying adenoviruses. Very faint endogenous Smad7 expression is observed in CAG/Cre-carrying adenovirus-infected specimen at day 10 (k), while prominent immunoreactivity for presumably exogenous Smad7 is seen in the cell multilayer formed in an injured lens coinfected with CAG/Cre-carrying adenovirus and LNL/Smad7-carrying adenovirus (l). Frames c, e, g, and i, indicate localization of nuclei as stained with DAPI in the frames d, f, h, and j, respectively. Dotted lines indicate anterior capsule. AC, anterior lens capsule; bar, 50 mm.
Smad7 blocks EMT in lens epithelium
S Saika et al (Figure 4c ), whereas faint immunoreactivity was detected in lens epithelial cells in the multilayer around the capsular break in the Smad7 adv-treated group (Figure 4d ). We then examined the expression of lumican and collagen type VI, components of fibrotic tissue, at days 5 and 10 postinjury. As expected, the results indicated that fibroblast-like lens epithelial cells were labeled with antilumican and anticollagen type VI only in the control group, and not in Smad7 adv-treated specimens ( Figure 5 ).
Epithelial Cell Proliferation
The TGFb/Smad pathway is potentially involved in suppression of cell proliferation in many organs/ tissues. We used BrdU incorporation to evaluate cell proliferation in the healing epithelium following exogenous Smad7 gene transfer. Epithelial cell proliferation was much higher in the Smad7 adenovirus group than in the Cre adenovirus group at day 5, but not at day 10 ( Figure 6 ). At day 5 BrdUlabeled cells were induced in both the equatorial and anterior epithelia in the Smad7 adenovirus group.
Expression of TGFb1 and TGFb2
Since introduction of the Smad7 gene blocked injury-induced EMT in lens epithelial cells, we examined if this expression suppresses injuryinduced upregulation of TGFb1 in lens epithelial cells. Uninjured lens epithelium expresses immunoreactive TGFb2 in its mid-peripheral region, but does not express TGFb1. Fibroblast-like, multilayered epithelial cells adjacent to the capsular break in the control group showed increased expression of TGFb1 following injury, whereas Smad7 blocks EMT in lens epithelium S Saika et al multilayered cells in the Smad7 gene-transfer group were not labeled for either intracellular or extracellular TGFb1 (Figure 7a-d) . In the control group, TGFb2 immunoreactivity was reduced in fibroblastic lens cells generated through EMT, which accumulated around the capsular break at days 5 and 10 ( Figure 7e ). In the Smad7 adv-treated group, multilayered lens cells were of epithelial shape and were still markedly labeled for TGFb2 (Figure 7f) .
Discussion
The present study shows that transient adenoviral gene transfer of Smad7 cDNA prevents injuryinduced EMT in lens epithelial cells in association with enhancement of cell proliferation in mice in vivo. Introduction of Smad7 also abolishes upregulation of snail, aSMA and extracellular matrix components. Smad7 blocks signaling from both Smad2 and Smad3 and activated Smads 2 and 3 have distinct roles in gene regulation based upon the results of gene-expression array studies. 39, 40 Moreover, it has been reported that conversion of fibroblasts to aSMA-expressing myofibroblasts depends on Smad2, but that expression of extracellular matrix components, that is, collagen types, is Smad3-dependent. [41] [42] [43] However, EMT, a process of phenotypic conversion from an epithelial cell type to a myofibroblastic cell type, is believed to differ mechanistically from that of fibroblast-myofibroblast conversion. We previously showed that Smad3 signaling is required for injury-induced EMT of lens epithelial cells and renal tubular epithelial cells, 16, 17 but not for generation of myofibroblasts from fibroblasts in healing dermal tissue. 37 These and other data suggest that Smad3 is required in the very early phases of injuryinduced EMT, whereas Smad2 might be important in the later phases of the process. Introduction of the Smad7 gene blocks injury-induced EMT in lens epithelial cells possibly via blocking Smad3 signaling.
Transient introduction of the Smad7 gene by using an adenoviral vector is reportedly effective Figure 3 Expression of snail mRNA in injured lens epithelium as detected by in situ hybridization. The uninjured lens epithelium does not express snail mRNA (data not shown). Injured lens epithelium upregulates snail mRNA at day 5 (a) and then its expression increases at day 10 (c), whereas Smad7 gene introduction abolishes snail expression in injured epithelium at day 5 (b) with very faint snail expression being detected in the cells of Smad7 vector-treated specimens at day 10 (d). No specific signal was detected in specimens labeled with the sense probe (e). White or black asterisks indicate the cell multilayers composed of fibroblastic lens cells that are labeled for snail mRNA or lens cell masses without snail mRNA labeling. AC, anterior capsule, bar, 40 mm.
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S Saika et al in treating inflammatory/fibrotic disorders in lung, kidney, and liver. [28] [29] [30] In these tissues, Smad7 gene transfer not only suppresses the conversion of interstitial fibroblasts (including liver stellate cells) to aSMA-expressing myofibroblasts, but also inhibits extracellular matrix expression. While, the mechanism of generation of aSMA-positive myofibroblasts might differ among organs, 44, 45 it would be blocked by Smad7 gene transfer even if it was a Smad2-dependent process. Blocking TGFb action at the receptor level may block various signaling cascades potentially activated upon ligand binding to the receptor, such as MAP kinase pathways in addition to Smad signaling. Blocking injury-induced EMT of lens epithelium by Smad7 gene transfer, or by knocking out Smad3, indicates it is not necessary to block non-Smad TGFb signaling to suppress EMT.
Our previous study in lens epithelial cells showed that loss of Smad3 results in the abrogation of upregulation of TGFb1 and extracellular matrix components, which was mimicked by gene transfer of Smad7 into the lens in the present study. In contrast, expression of TGFb2 in the peripheral epithelium of an injured lens and in the central epithelium around the capsular break was similar in the Cre-and Smad7-treated groups, consistent with the observation that autoinduction of TGFb1, but not expression of TGFb2, is dependent upon Smad3.
The TGFb/Smad pathway is also potentially involved in regulation (mainly suppression) of cell proliferation in many organs/tissues. 24 We show here that Smad7 overexpression enhances the injury-induced proliferation of lens epithelial cells. Interestingly, this was not observed following lens injury in Smad3-null mice. 17 Since loss of Smad3 alone does not affect cell proliferation in an injured lens, 17 it suggests that inhibition of cell proliferation in the injured lens epithelium might require either Smad2 or both Smad2 and Smad3, possibly in cooperation with Smad-independent pathways. We have also observed that loss of Smad3 does not affect cell proliferation in the injured corneal epithelium (S Saika, WW-Y Kao, AB Roberts, unpublished data, 2003), whereas it stimulates keratinocyte proliferation following epidermal injury, 46 indicating that regulation of cell proliferation by TGFb/Smad signaling is tissue-specific. 
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Clinically, after-cataract tissue is characterized by fibrous opacification and regeneration of lenticular fibers of Sommerring's ring and Elschnig's pearl formation, and is accompanied by lens epithelial cell proliferation. 8 Using dominant-negative TGFb receptor expression driven by the a-crystallin promoter, de Iongh et al 47 reported that lenticular fiber cells require TGFb isoforms for lens fiber maturation during development. However, it is not known as to which signaling cascade(s) is (are) used because the TGFb receptor potentially activates both Smad and non-Smad signaling cascades, that is, MAPK-Erk pathway, p38MAPK, or c-Jun-Nterminal kinase cascade. 27, 48 This is further supported by detection of both TGFb receptors types I and II in postoperative lens epithelial cells in the equator region of the residual lens capsule. We have reported that elongated, fiber-differentiating, lens cells lack nuclear Smad3/4, suggesting that postoperative fiber regeneration does not require TGFb signaling or is controlled by non-Smaddependent TGFb signaling. 15 Thus, it is of interest to examine if postoperative lens fiber regeneration is effectively blocked by Smad7 cDNA , although another animal model will be needed to answer this question.
In conclusion, lens capsular contraction by fibrosis is clinically unfavorable and blocking Smad signaling, in association with a therapy to suppress cell proliferation, may be a strategy to prevent this clinical problem. In injury-induced cell proliferation in lens epithelium, we have shown that loss of fibroblast growth factor 2 (FGF2) reduces cell proliferation, whereas it does not affect the physiological proliferation in an intact mouse lens. This result suggests that blocking FGF2 activity might be potentially used to suppress an abnormal cell proliferation in an Protein expression pattern of transforming growth factor b1 and b2 (TGFb1 and b2) in injured lenses. TGFb1 protein is upregulated in anterior lens epithelial cells with a fibroblastic appearance adjacent to the capsular break at day 5 (a, arrows) and is more intensely expressed there at day 10 (c, arrows) in control lenses, while it is not detected in multilayered lens epithelial cells (asterisks) around the break in Smad7 gene-transferred lenses at day 5 (b) and 10 (d). TGFb2 is expressed in peripheral lens epithelium, but not in anterior epithelium in an uninjured lens (not shown). TGFb2 is then upregulated postinjury at day 5 (not shown) and day 10 (e, f) in both control (e, arrows) and Smad7 gene-transfer specimens (f, asterisk); bar, 40 mm.
Smad7 blocks EMT in lens epithelium
S Saika et al
